I-δ1 |
α-Keto-butyrate |
|
60 mg/L |
– |
Incompatible with A labeling. |
CIL, Isotec, NMR-Bio |
[1] |
|
2-(S)-Hydroxy-2-ethyl-3-keto-butyrate |
|
60 mg/L |
– |
Compatible with A labeling |
NMR-Bio |
[45] |
M-ε
|
l-Methionine |
|
250 mg/L |
– |
– |
CIL, Isotec, NMR-Bio |
[72] |
L-δ/V-γ racemic pro-R pro-S |
α-Keto-isovalerate |
|
120 mg/L |
– |
– |
CIL, Isotec, NMR-Bio |
[4] |
L-δ1, δ2/V-γ1, γ2 |
α-Keto-isovalerate |
|
120 mg/L |
– |
This labeling scheme works best to establish intra-residue resonance pairings for L and V, less so for long range NOEs |
Isotec |
[2] |
V-γ |
α-Keto-isovalerate |
Either of the above two precursors |
120 mg/L |
10% deuterated Bioexpress or Isogro |
Addition of Bioexpress/Isogro has been observed to decrease I-δ1 and T-γ2 incorporation. Use to distinguish L/V resonances If also labeling I-δ1, add α-acetolactate 1 h before induction and α-ketobutyrate 20 min before induction |
CIL, Isotec, or NMR-BioCIL, Isotec for supplement NMR-Bio |
[52] |
L-δ/V-γ pro-S |
2-(S)-Aceto-lactate |
|
300 mg/L |
– |
[50] |
A-β |
l-Alanine |
|
600 mg/L |
200 mg/L deuterated α-ketoisovalerate, 60 mg/L deuterated isoleucine (unless labeling L/V or I) |
Scrambling to I-γ2 makes this label incompatible with α-ketobutyrate I labeling for NOE studies. 2-(S)-hydroxy-2-ethyl-3-ketobutyrate must be used instead for this scenario |
CIL, Isotec, NMR-Bio |
[45,49] |
T-γ2 |
l-Threonine |
|
50 mg/L |
60 mg/L deuterated α-ketobutyrate (unless also labeling I-δ1) and 100mg/L deuterated Gly |
– |
CIL, Isotec, NMR-Bio |
[46] |